Jyong Biotech Ltd. Ordinary Shares financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

제이융 바이오테크NASDAQ:MENS · Nasdaq

$2.02-1.46%

2026-10-06 close · prelim

Jyong Biotech Ltd. Ordinary Shares's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$2M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy